1. Staging systems of hepatocellular carcinoma: A review
   Sreeshma Tellapuri et al, 2018, Indian Journal of Gastroenterology CrossRef
2. Scoring systems for the management of oncological hepato-pancreato-biliary patients
   Alexander W. Coombs et al, 2022, Annals of Hepato-Biliary-Pancreatic Surgery CrossRef
3. Overview of Clinical HCC and Its Management
   Brian I. Carr, 2021, Liver Cancer in the Middle East CrossRef
4. Prognostic Value of Macrophage-Associated Long Non-Coding RNA Expression for Hepatocellular Carcinoma
   Guan-Yu Chen et al, 2022, Cancer Management and Research CrossRef
5. Another treatment option for locally advanced hepatocellular carcinoma: Interventional arterial infusion of FOLFOX chemotherapy from the FOHAIC-1 study
   Ning Lyu et al, 2022, Visualized Cancer Medicine CrossRef
6. A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy
   Yang‐Xun Pan et al, 2019, Cancer Communications CrossRef
7. Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations
   Ming Zhao et al, 2024, Hepatology International CrossRef
8. Novel Nomograms Based on Gamma-Glutamyl Transpeptidase-to-Lymphocyte Ratio Predict Prognosis of Hepatocellular Carcinoma Patients After Hepatectomy
   Cheng Ma et al, 2023, Journal of Hepatocellular Carcinoma CrossRef
9. Prognostic evaluation of HCC patients undergoing surgical resection: an analysis of 8 different staging systems
   Jan Bednarsch et al, 2021, Langenbeck's Archives of Surgery CrossRef
10. Prognosis of Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization(MC-hccAI 001): Development and Validation of the ALFP Score
    Baocuo Gong et al, 2023, Journal of Hepatocellular Carcinoma CrossRef
11. An immune-related biomarker index for predicting the effectiveness of immunotherapy and prognosis in hepatocellular carcinoma
    Xiang’an Wu et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
12. G Protein-Coupled Receptor Kinase 4 Is a Novel Prognostic Factor in Hepatocellular Carcinoma
    Yunxiu Luo et al, 2022, Disease Markers CrossRef
13. Enhanced antitumour effect for hepatocellular carcinoma in the advanced stage using a cyclodextrin-sorafenib-chaperoned inclusion complex
    Chiuyen Phan et al, 2019, Biomaterials Science CrossRef
14. Evaluation and Application of Drug Resistance by Biomarkers in the Clinical Treatment of Liver Cancer
    Po-Shuan Huang et al, 2023, Cells CrossRef
15. Machine learning-based development and validation of a scoring system for progression-free survival in liver cancer
    Xiaoli Liu et al, 2020, Hepatology International CrossRef
16. Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study.
    Giovanni Marasco et al, 2021, Digestive and Liver Disease CrossRef
17. Dynamically prognosticating patients with hepatocellular carcinoma through survival paths mapping based on time-series data
    Lujun Shen et al, 2018, Nature Communications CrossRef
18. Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC Classifications
    Alessandro Vitale et al, 2021, Cancers CrossRef